At a glance
- Originator Pierre Fabre
- Class Antidepressants; Small molecules
- Mechanism of Action Serotonin 1B receptor inverse agonists; Serotonin 1D receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 12 May 1999 Discontinued-Preclinical for Depression in France (Unknown route)
- 28 Oct 1998 Preclinical development for Depression in France (Unknown route)